Abstract
The role of chemotherapy in the management of advanced prostate cancer is expanding. Multiple regimens that use a variety of drugs have been developed. A chemotherapy regimen may appear to be a collection of randomly chosen agents. This article presents the theoretic foundation for the development of combination chemotherapy.
Original language | English (US) |
---|---|
Pages (from-to) | 275-279 |
Number of pages | 5 |
Journal | Urologic Clinics of North America |
Volume | 26 |
Issue number | 2 |
DOIs | |
State | Published - 1999 |
Externally published | Yes |
ASJC Scopus subject areas
- Urology